Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Stock
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
27.2M
-
Shares change
-
-3.1M
-
Total reported value, excl. options
-
$13.3M
-
Value change
-
-$1.66M
-
Number of buys
-
15
-
Number of sells
-
-16
-
Price
-
$0.49
Significant Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q2 2022
47 filings reported holding CDTX - CIDARA THERAPEUTICS INC COM NEW - Stock as of Q2 2022.
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.2M shares
.
Largest 10 shareholders include BVF INC/IL (6.86M shares), Nantahala Capital Management, LLC (4.82M shares), Point72 Asset Management, L.P. (4.2M shares), VANGUARD GROUP INC (2.46M shares), ALETHEA CAPITAL MANAGEMENT, LLC (1.68M shares), RENAISSANCE TECHNOLOGIES LLC (1.16M shares), 5AM Venture Management, LLC (1.13M shares), ACADIAN ASSET MANAGEMENT LLC (1.11M shares), Knott David M Jr (635K shares), and GEODE CAPITAL MANAGEMENT, LLC (502K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.